2012

Questioning Traditions through Modern Clinimetrics

Dr Ingemar Merkies
Spaarne Hospital, Hoofddorp, The Netherlands
3rd December, 33 Queen Square

Genetic Defects of Neuromuscular Transmission

Professor Hanns Lochmuller
Institute of Human Genetics, Newcastle University
15th October, 33 Queen Square

Phosphoinositide metabolism and Schwann cell myelination (Bolino) Role of c-Jun activating binding protein 1 (Jab1) in Congenital muscular dystrophy type 1A (MCD1A) associated neuropathy: a new molecule in the laminin2 pathway? (Previtali)

Dr Alessandro Bolino & Dr Stefano Previtali
San Raffaele Ospedale, Italy
17th September, 33 Queen Square

Clinical Trials in Charcot-Marie-Tooth Disease

Dr David Pareyson
IRCCS Foundation, Milan, Italy
9th July, 33 Queen Square

Next generation sequencing in Charcot-Marie-Tooth disease

Dr Michaela Auer-Grumbach
Institute of Medical Biology and Human Genetics, Graz, Austria
18th June, Queen Square

Using mouse models to investigate the dystroglycanopathies

Dr Sue Brown
Royal Veterinary College, University of London
12th June, Queen Square

Unraveling the role of aminoacyl-tRNA synthetases in peripheral neurodegeneration - a flying perspective

Prof. Albena Jordanova
University of Antwerp
29th May, Queen Square

Developments in diagnostics and research for FSHD

Dr Nicolas Levy
Universite de la Mediterranee, Marseille, France
8th May, Queen Square

Studying Schwann cell remyelination following neural injury

Dr David Bennett
Neurorestoration Group, King's College London
16th April, Queen Square

ATP signalling in dystrophic muscles

Prof Darek Gorecki
Portsmouth University
13th March, Newcastle University

Cell therapy for muscular dystrophy: present and future options

Dr Giulio Cossu
Department of Cell and Developmental Biology, UCL
5th March, Queen Square

Mitochondrial diseases: from molecules to treatments

Professor Patrick Chinnery
Newcastle University
6th February, Queen Square